✦ LIBER ✦

Outcomes of Lung Transplantation in Patients with Scleroderma

✍ Scribed by Malek G. Massad; Charles R. Powell; Jacques Kpodonu; Cimenga Tshibaka; Ziad Hanhan; Norman J. Snow; Alexander S. Geha

Publisher: Springer
Year: 2005
Tongue: English
Weight: 98 KB
Volume: 29
Category: Article
ISSN: 0364-2313
DOI: 10.1007/s00268-005-0017-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical course of lung physiology in pa

Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: Analysis of the Scleroderma Lung Study Placebo Group

✍ Dinesh Khanna; Chi-Hong Tseng; Niloofar Farmani; Virginia Steen; Daniel E. Furst 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

Outcome of liver transplantation in pati

Outcome of liver transplantation in patients with hemochromatosis

✍ Frank J. Farrell; Marie Nguyen; Susan Woodley; Joanne C. Imperial; Richard Garci 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 723 KB

Recent preliminary reports suggest a poor outcome of orthotopic liver transplantation for patients with hemochromatosis. We analyzed an institutional experience with orthotopic liver transplantation for hemochromatosis, focusing on factors contributing to increased morbidity and mortality. Between M

D-penicillamine treatment of lung involv

D-penicillamine treatment of lung involvement in patients with systemic sclerosis (scleroderma)

✍ Thomas A. Medsger Jr. 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB 👁 2 views

D-penicillamine has been used to treat systemic sclerosis (scleroderma) for nearly two decades. Improvement in cutaneous fibrosis in patients treated with this drug has been documented in a number of uncontrolled studies (1). The effect of D-penicillamine on established visceral involvement due to s

Lung transplantation in scleroderma comp

Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension

✍ Lionel Schachna; Thomas A. Medsger Jr.; James H. Dauber; Fredrick M. Wigley; Nei 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## Abstract ## Objective Lung transplantation is a viable, life‐saving intervention for several primary pulmonary disorders complicated by severe lung dysfunction. This study was undertaken to evaluate whether patients with systemic sclerosis (scleroderma), a systemic autoimmune rheumatic disorder

Predicting treatment outcomes and respon

Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease

✍ Michael D. Roth; Chi-Hong Tseng; Philip J. Clements; Daniel E. Furst; Donald P. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB

Impact of oral cyclophosphamide on healt

Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: Results from the scleroderma lung study

✍ Dinesh Khanna; Xiaohong Yan; Donald P. Tashkin; Daniel E. Furst; Robert Elashoff 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## Abstract ## Objective To assess the impact of cyclophosphamide (CYC) on the health‐related quality of life (HRQOL) of patients with scleroderma after 12 months of treatment. ## Methods One hundred fifty‐eight subjects participated in the Scleroderma Lung Study, with 79 each randomized to CYC